MONT-SAINT-GUIBERT, Belgium, March 19, 2019 /PRNewswire/ -- Nyxoah S.A., a healthtech company focusing on the development of innovative solutions and services for sleep related disorders, today ...

H.C. Wainwright analyst Edward White has reiterated their bullish stance on NYXH stock, giving a Buy rating on September 18. Edward White has given his Buy rating due to a combination of factors ...

(RTTNews) - Nyxoah S.A. (NYXH) has announced the commercial launch of its Genio system in the Middle East, with the first successful implant performed at Saudi German Hospital in Dubai, UAE. Genio is ...

Mont-Saint-Guibert, Belgium – April 8, 2025, 07:00am CET / 1:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), which develops breakthrough treatment alternatives for ...

Mont-Saint-Guibert, Belgium – March 26, 2025, 8:00am CET / 3:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for ...

Nyxoah NYXH has begun its U.S. commercial rollout of the Genio system, following FDA approval for its leadless, battery-free neurostimulation therapy for obstructive sleep apnea (OSA). The first ...

Nyxoah ( ($NYXH) ) has issued an update. On December 17, 2025, Nyxoah announced the commercial launch of its Genio hypoglossal neurostimulation ...

Nyxoah (NYXH) announced the commercial launch of its Genio system in England, marked by the first successful implants performed at University College London Hospitals. TipRanks is the most ...

Assignment to New Technology APC 1580 is positive news for Nyxoah’s U.S. commercial rollout by strengthening hospital and ASC economics Mont-Saint-Guibert, Belgium – November 26, 2025, 7:45 am CET / 1 ...

Mont-Saint-Guibert, Belgium – August 8, 2025, 10:10pm CET / 4:10pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough ...